No headlines found.
No press releases found.
No news found.
The SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the Index ).The S&P Pharmaceuticals Select Industry Index (the Index ) represents the pharmaceuticals segment of the S&P Total Market Index ( S&P TMI ). The S&P TMI is designed to track the broad U.S. equity market. The pharmaceuticals segment of the S&P TMI comprises the Pharmaceuticals sub-industry. The Index is one of twenty-one (21) of the S&P Select Industry Indices (the Select Industry Indices ), each designed to measure the performance of a narrow sub-industry or group of sub-industries determined based on the Global Industry Classification Standard ( GICS ).
SPDR S&P Pharmaceuticals ETF trades on the ARCA stock market under the symbol XPH.
As of May 8, 2024, XPH stock price climbed to $40.93 with 17,535 million shares trading.
XPH has a beta of 0.92, meaning it tends to be less sensitive to market movements. XPH has a correlation of 0.37 to the broad based SPY ETF.
XPH has a market cap of $198.52 million. This is considered a Micro Cap stock.
In the last 3 years, XPH stock traded as high as $53.82 and as low as $34.67.
XPH has underperformed the market in the last year with a return of -2.2%, while the SPY ETF gained +27.0%. In the last 3 month period, XPH fell short of the market, returning -4.3%, while SPY returned +4.2%. However, in the most recent 2 weeks XPH has outperformed the stock market by returning +2.9%, while SPY returned +2.3%.
XPH support price is $40.26 and resistance is $41.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XPH stock will trade within this expected range on the day.